New	0	3	O
vectors	4	11	O
and	12	15	O
strategies	16	26	O
for	27	30	O
cardiovascular	31	45	O
gene	46	50	O
therapy	51	58	O
.	58	59	O

Cardiovascular	61	75	O
diseases	76	84	O
are	85	88	O
the	89	92	O
major	93	98	O
cause	99	104	O
of	105	107	O
morbidity	108	117	O
and	118	121	O
mortality	122	131	O
in	132	134	O
both	135	139	O
men	140	143	B-Organism
and	144	147	O
women	148	153	B-Organism
in	154	156	O
industrially	157	169	O
developed	170	179	O
countries	180	189	O
.	189	190	O

These	191	196	O
disorders	197	206	O
may	207	210	O
result	211	217	O
from	218	222	O
impaired	223	231	O
angiogenesis	232	244	O
,	244	245	O
particularly	246	258	O
in	259	261	O
response	262	270	O
to	271	273	O
hypoxia	274	281	O
.	281	282	O

Despite	283	290	O
many	291	295	O
limitations	296	307	O
,	307	308	O
gene	309	313	O
therapy	314	321	O
is	322	324	O
still	325	330	O
emerging	331	339	O
as	340	342	O
a	343	344	O
potential	345	354	O
alternative	355	366	O
for	367	370	O
patients	371	379	B-Organism
who	380	383	O
are	384	387	O
not	388	391	O
candidates	392	402	O
for	403	406	O
traditional	407	418	O
revascularization	419	436	O
procedures	437	447	O
,	447	448	O
like	449	453	O
angioplasty	454	465	O
or	466	468	O
vein	469	473	B-Multi-tissue_structure
grafts	474	480	I-Multi-tissue_structure
.	480	481	O

This	482	486	O
review	487	493	O
focuses	494	501	O
on	502	504	O
recent	505	511	O
approaches	512	522	O
in	523	525	O
the	526	529	O
development	530	541	O
of	542	544	O
new	545	548	O
gene	549	553	O
delivery	554	562	O
vectors	563	570	O
,	570	571	O
with	572	576	O
great	577	582	O
respect	583	590	O
to	591	593	O
newly	594	599	O
discovered	600	610	O
AAV	611	614	B-Drug_or_compound
serotypes	615	624	I-Drug_or_compound
and	625	628	O
their	629	634	O
modified	635	643	O
forms	644	649	O
.	649	650	O

Moreover	651	659	O
,	659	660	O
some	661	665	O
new	666	669	O
cardiovascular	670	684	O
gene	685	689	O
therapy	690	697	O
strategies	698	708	O
have	709	713	O
been	714	718	O
highlighted	719	730	O
,	730	731	O
such	732	736	O
as	737	739	O
combination	740	751	O
of	752	754	O
different	755	764	O
angiogenic	765	775	O
growth	776	782	O
factors	783	790	O
or	791	793	O
simultaneous	794	806	O
application	807	818	O
of	819	821	O
genes	822	827	O
and	828	831	O
progenitor	832	842	B-Cell
cells	843	848	I-Cell
in	849	851	O
order	852	857	O
to	858	860	O
obtain	861	867	O
stable	868	874	O
and	875	878	O
functional	879	889	O
blood	890	895	B-Multi-tissue_structure
vessels	896	903	I-Multi-tissue_structure
in	904	906	O
ischemic	907	915	B-Tissue
tissue	916	922	I-Tissue
.	922	923	O

